Ascendis Pharma (ASND)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
9 |
$777,067 |
| Sells |
3 |
$5,513,926 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 18 Aug 2026 |
BIENAIME JEAN JACQUES |
Director |
14 Aug 2026 |
900 |
246.91 |
222,219 |
| 18 Aug 2026 |
BIENAIME JEAN JACQUES |
Director |
14 Aug 2026 |
1,100 |
245.85 |
270,435 |
| 02 Jun 2026 |
SMITH SCOTT THOMAS |
EVP & Chief Financial Officer |
02 Jun 2026 |
100 |
219.00 |
21,900 |
| 01 Jun 2026 |
BIENAIME JEAN JACQUES |
Director |
29 May 2026 |
200 |
222.30 |
44,460 |
| 01 Jun 2026 |
BIENAIME JEAN JACQUES |
Director |
29 May 2026 |
200 |
223.76 |
44,752 |
| 01 Jun 2026 |
BIENAIME JEAN JACQUES |
Director |
29 May 2026 |
100 |
223.50 |
22,350 |
| 01 Jun 2026 |
SMITH SCOTT THOMAS |
EVP & Chief Financial Officer |
29 May 2026 |
250 |
223.32 |
55,830 |
| 27 May 2026 |
BIENAIME JEAN JACQUES |
Director |
26 May 2026 |
200 |
236.24 |
47,247 |
| 27 May 2026 |
BIENAIME JEAN JACQUES |
Director |
26 May 2026 |
200 |
239.37 |
47,874 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock